278 related articles for article (PubMed ID: 29391408)
1. Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination.
Lentferink DH; Jongsma JM; Werkman I; Baron W
Sci Rep; 2018 Feb; 8(1):2113. PubMed ID: 29391408
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional heterogeneity between primary adult grey and white matter astrocytes underlie differences in modulation of in vitro myelination.
Werkman IL; Dubbelaar ML; van der Vlies P; de Boer-Bergsma JJ; Eggen BJL; Baron W
J Neuroinflammation; 2020 Dec; 17(1):373. PubMed ID: 33308248
[TBL] [Abstract][Full Text] [Related]
3. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.
Strijbis EMM; Kooi EJ; van der Valk P; Geurts JJG
J Neuropathol Exp Neurol; 2017 May; 76(5):390-401. PubMed ID: 28521040
[TBL] [Abstract][Full Text] [Related]
4. Impairing committed cholesterol biosynthesis in white matter astrocytes, but not grey matter astrocytes, enhances in vitro myelination.
Werkman IL; Kövilein J; de Jonge JC; Baron W
J Neurochem; 2021 Mar; 156(5):624-641. PubMed ID: 32602556
[TBL] [Abstract][Full Text] [Related]
5. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
Lau LW; Keough MB; Haylock-Jacobs S; Cua R; Döring A; Sloka S; Stirling DP; Rivest S; Yong VW
Ann Neurol; 2012 Sep; 72(3):419-32. PubMed ID: 23034914
[TBL] [Abstract][Full Text] [Related]
7. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Skaper SD
Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
[TBL] [Abstract][Full Text] [Related]
8. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
9. Viscoelastic properties of white and gray matter-derived microglia differentiate upon treatment with lipopolysaccharide but not upon treatment with myelin.
van Wageningen TA; Antonovaite N; Paardekam E; Brevé JJP; Iannuzzi D; van Dam AM
J Neuroinflammation; 2021 Mar; 18(1):83. PubMed ID: 33781276
[TBL] [Abstract][Full Text] [Related]
10. Dl-3-n-butylphthalide promotes remyelination process in cerebral white matter in rats subjected to ischemic stroke.
Cheng X; Wang H; Liu C; Zhong S; Niu X; Zhang X; Qi R; Zhao S; Zhang X; Qu H; Zhao C
Brain Res; 2019 Aug; 1717():167-175. PubMed ID: 30986406
[TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator exerts EGF-like chemokinetic effects on oligodendrocytes in white matter (re)myelination.
Leonetti C; Macrez R; Pruvost M; Hommet Y; Bronsard J; Fournier A; Perrigault M; Machin I; Vivien D; Clemente D; De Castro F; Maubert E; Docagne F
Mol Neurodegener; 2017 Feb; 12(1):20. PubMed ID: 28231842
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
[TBL] [Abstract][Full Text] [Related]
13. Developing oligodendrocytes express functional GABA(B) receptors that stimulate cell proliferation and migration.
Luyt K; Slade TP; Dorward JJ; Durant CF; Wu Y; Shigemoto R; Mundell SJ; Váradi A; Molnár E
J Neurochem; 2007 Feb; 100(3):822-40. PubMed ID: 17144904
[TBL] [Abstract][Full Text] [Related]
14. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Xiao L; Guo D; Hu C; Shen W; Shan L; Li C; Liu X; Yang W; Zhang W; He C
Glia; 2012 Jul; 60(7):1037-52. PubMed ID: 22461009
[TBL] [Abstract][Full Text] [Related]
15. Co-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells.
Skaper SD; Barbierato M; Facci L; Borri M; Contarini G; Zusso M; Giusti P
Mol Neurobiol; 2018 Jan; 55(1):103-114. PubMed ID: 28822061
[TBL] [Abstract][Full Text] [Related]
16. Nogo receptor blockade overcomes remyelination failure after white matter stroke and stimulates functional recovery in aged mice.
Sozmen EG; Rosenzweig S; Llorente IL; DiTullio DJ; Machnicki M; Vinters HV; Havton LA; Giger RJ; Hinman JD; Carmichael ST
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8453-E8462. PubMed ID: 27956620
[TBL] [Abstract][Full Text] [Related]
17. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination.
Stangel M; Bernard D
J Neuroimmunol; 2003 May; 138(1-2):25-30. PubMed ID: 12742649
[TBL] [Abstract][Full Text] [Related]
18. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Cui QL; Kuhlmann T; Miron VE; Leong SY; Fang J; Gris P; Kennedy TE; Almazan G; Antel J
Am J Pathol; 2013 Aug; 183(2):516-25. PubMed ID: 23746653
[TBL] [Abstract][Full Text] [Related]
19. Interaction between microglia and oligodendrocyte cell progenitors involves Golli proteins.
Filipović R; Zecević N
Ann N Y Acad Sci; 2005 Jun; 1048():166-74. PubMed ID: 16154930
[TBL] [Abstract][Full Text] [Related]
20. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
